Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The mean absolute bioavailability of BPC157 following IM injection was approximately 14%19% in rats and 45%51% in beagle dogs
Dosage 2 capsules daily with a meal for best absorption
Patients from any state can begin treatment by booking a Peptide Consult through our online booking system
Qian, Z
What the Evidence Actually Supports Its worth being precise about the state of evidence, because the gap between preclinical research and proven human clinical outcomes is significant in this area: Strong preclinical evidence: Hundreds of cell culture and animal studies demonstrate GHK-Cus biological activity across multiple pathways Moderate clinical evidence for topical applications: Several controlled human trials support skin benefits of topical GHK-Cu formulations Limited human evidence for systemic effects: The more dramatic claims tissue regeneration, gene expression reset, anti-aging effects throughout the body are largely supported by in vitro and animal data without the controlled human trials required to confirm efficacy and safety The scientific communitys interest in GHK-Cu is well-founded
Compounds in this category are studied in preclinical research models examining the incretin axis GLP-1, GIP, glucagon, and amylin receptor pharmacology
